Levosimendan attenuates myocardial injury induced by coronary microembolization in swine by inhibiting myocardial inflammation and apoptosis
Aims: In addition to its cardiotonic effect, Levosimendan (Levo) has been thought to have multiple cardiovascular benefits, including anti-inflammatory and anti-apoptotic effects. The present study was undertaken to determine whether the Levo pretreatment could attenuate myocardial apoptosis and inf...
Main Authors: | Han Chen, Jiang-You Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Cardiology Plus |
Subjects: | |
Online Access: | http://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2019;volume=4;issue=4;spage=103;epage=110;aulast=Chen |
Similar Items
-
Levosimendan Pretreatment Inhibits Myocardial Apoptosis in Swine after Coronary Microembolization
by: Lang Li, et al.
Published: (2017-01-01) -
Atorvastatin Inhibits Myocardial Apoptosis in a Swine Model of Coronary Microembolization by Regulating PTEN/PI3K/Akt Signaling Pathway
by: Jiangyou Wang, et al.
Published: (2016-01-01) -
Protective effect of glycyrrhizin on coronary microembolization‐induced myocardial dysfunction in rats
by: Yonggang Yuan, et al.
Published: (2021-02-01) -
TAK-242 Protects Against Apoptosis in Coronary Microembolization-Induced Myocardial Injury in Rats by Suppressing TLR4/NF-κB Signaling Pathway
by: Xian-tao Wang, et al.
Published: (2017-03-01) -
Proteomics Analysis of Myocardial Tissues in a Mouse Model of Coronary Microembolization
by: Ao Chen, et al.
Published: (2018-09-01)